Breast cancer clinical registry

The Breast Cancer Clinical Registry (KrMam) was established in 2023. Data is entered into the KrMam for all patients with invasive and non-invasive breast cancer (C50 and D05 according to ICD-10). Compared to the dataset collected by the Cancer Registry, the KrMam obtains additional data from the DORA screening programme and pathology laboratories on the type of disease and the diagnostic method, as well as from oncologists, radiotherapists and surgeons on the treatment method and response to treatment. 

A set of quality of care indicators has also been adopted by the Breast Cancer Expert Group of the National Cancer Control Programme and will be monitored by the KrMam.